Vapotherm, Inc. is the inventor of high flow nasal cannula, and its advanced form: Vapotherm high velocity therapy. Delivering high velocity therapy, the Precision Flow® system offers clinicians a reliable tool for multiple patient populations. For respiratory distress patients presenting in the ED and ICU, high velocity therapy can provide not just oxygenation, but also Mask-Free NIV®—ventilatory support with the comfort of heated humidified high flow.
Location: United States, New Hampshire, Exeter
Employees: 201-500
Phone: +1 844-381-8276
Founded date: 1999
Investors 5
| Date | Name | Website |
| - | Ally Bridg... | ally-bridg... |
| - | Kaiser Per... | kpventures... |
| - | CIBC Innov... | innovation... |
| - | 3x5 Partne... | 3x5partner... |
| - | Lightstone... | lightstone... |
Mentions in press and media 3
| Date | Title | Description |
| 29.01.2025 | Infinium Medical Enters Exclusive Veterinary Partnership with Vapotherm for Next-Gen High-Flow Oxygen Therapy Systems | Vapotherm VET 2.0 Veterinary High-Flow Oxygen Therapy System Infinium Medical, through its Infinium Veterinary division will be exclusively distributing Vapotherm VET 2.0 high-velocity respiratory therapy systems. This partnership allows us... |
| 12.08.2024 | Vapotherm Reports Second Quarter 2024 Financial Results | EXETER, N.H., Aug. 12, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced second quarter 2024 financial results and related highlights. Second Quarter 2024 Financial Resul... |
| 17.06.2024 | Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private | EXETER, N.H., June 17, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has signed a definitive merger agreement with a newly-formed entity organized and funded ... |